William Hugh McCauley Jr.
Known title: Chief Financial OfficerCIK: 0001983321
William Hugh McCauley Jr.'s purchase track record
William Hugh McCauley Jr. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/4/2025 | ABX | $192K | +14.0% | +17.8% | +14.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ABX | ▼ Sell | Open Market | 125,000 | $1.1M | 8/20/2026 | View on chart |
| ABX | ▼ Sell | Tax Withholding | 65,583 | $778K | 7/3/2026 | View on chart |
| ABX | ▼ Sell | Tax Withholding | 46,927 | $426K | 5/8/2026 | View on chart |
| ABX | ▲ Buy | Grant | 357,770 | $3.6M | 3/12/2026 | View on chart |
| ABX | ▲ Buy | Grant | 283,333 | $0 | 7/3/2025 | View on chart |
| ABX | ▲ Buy | Open Market | 33,000 | $192K | 6/4/2025 | View on chart |
| ABX | ▲ Buy | Option Exercise | 50,000 | — | 7/3/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Abacus Global Management to Report Q3 2026 Results Nov 5
Abacus Global Management is scheduled to release its third-quarter 2026 financial results on November 5. The company also announced a partnership to integrate its LifeARC product into the Retirable platform. These developments provide upcoming catalysts for the stock, which is currently trading near its 52-week low.
Abacus Global Management to Report Q3 2026 Results Nov 5. Abacus Global Management is scheduled to release its third-quarter 2026 financial results on November 5. The company also announced a partnership to integrate its LifeARC product into the Retirable platform. These developments provide upcoming catalysts for the stock, which is currently trading near its 52-week low.